J. Craig Venter Institute, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 29
Rang # Quantité totale PI 50 087
Note d'activité PI 2/5.0    14
Rang # Activité PI 61 877
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

19 4
0 0
6 0
0
 
Dernier brevet 2024 - Common cold coronavirus t cell e...
Premier brevet 1995 - Macrophage migration inhibitory ...
Dernière marque 2019 - JCVI J. CRAIG VENTER INSTITUTE
Première marque 2007 - J. CRAIG VENTER INSTITUTE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Common cold coronavirus t cell epitopes, methods and uses thereof. The present invention include...
2023 Invention Methods and systems for determining dental caries. A sequencing module configured to provide meta...
2022 Invention Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan pa...
Invention Bacterial formulation. Aspects of the present invention relate to compositions of bacterial isola...
2021 Invention Generation of synthetic genomes. Methods for generating synthetic genomes, for example synthetic ...
2019 Invention Protein and peptide delivery systems and methods for making and using them. Provided are composi...
P/S Laboratory research in the field of genomics and metagenomics; medical research; product research...
Invention System and method for wireless detection of oral health status. The present disclosure describes ...
2018 Invention Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli. Disclosed herein ...
Invention Resolvin mimetic antibodies and uses thereof. Provided herein are compositions comprising a resol...
Invention Engineered microalgae with enhanced lipid production. Described herein are engineered microalgae ...
2017 Invention Nucleic acids and proteins from streptococcus groups a and b. Streptococcus pyogenes), including ...
2016 Invention Escherichia coli . E. coli responsible for neonatal meningitis (MNEC), and a subset of these that...
Invention Methods for cloning and manipulating genomes. Compositions and methods are disclosed herein for c...
2015 Invention Haemophilus influenzae type b. Polypeptides comprising various amino acid sequences derived from...
Invention Modified bat influenza viruses and their uses. Vaccine compositions useful for vaccination agains...
Invention Streptococcus groups a and b. Streptococcus pyogenes), including amino acid sequences and the cor...
Invention Modular energy recovering water treatment devices. A modular device that is optimized for prelim...
2014 Invention Methods and apparatus for transplantation of nucleic acid molecules. In exemplary implementations...
Invention Enterococcus faecalis bacteriophage and uses thereof. Enterococcus faecalis by therapeutic admini...
Invention Enterococcus faecalis bacteriophage and uses thereof. Bacteriophages are provided that infect str...
2013 Invention Crowding agent-induced nucleic acid transfer into a recipient host cell. The presently disclosed ...
Invention Pleated cathode electrode: high surface area, light-weight, modified packed-bed electrode for oxy...
2012 Invention Nucleic acids and proteins from streptococcus groups a and b. The invention provides proteins fr...
2011 Invention Neisseria meningitidis. Various specific meningococcal proteins are disclosed. The invention prov...
Invention Polypeptides from neisseria meningitidis. Polypeptides comprising Neisseria meningitidis amino a...
Invention Modular energy recovering water treatment devices. A modular device that is optimized for prelimi...
2010 Invention Streptococcus pneumoniae proteins and nucleic acids. The invention provides proteins and nucleic...
2009 Invention Amplification of single viral genomes. The present invention relates, e.g., to a method for ampl...
2008 Invention Methods of genome installation in a recipient host cell. The presently disclosed invention relate...
P/S Computer education training services; Conducting educational exhibitions in the nature of genomic...
2007 Invention Sequencing method. The present invention relates, e.g., to a method for isolating a DNA molecule...
Invention Sequencing method. The present invention relates, e.g., to a method for isolating a DNA molecule ...
Invention Polypeptides from neisseria meningitidis. Various specific meningococcal proteins are disclosed. ...
P/S Laboratory research in the field of genomics, metagenomics; Medical research; Product research an...
2006 Invention Installation of genomes or partial genomes into cells or cell-like systems. A method is provided ...
Invention Haemophilus influenzae type b. Polypeptides comprising various amino acid sequences derived...
Invention Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli. Disclosed he...
2005 Invention Group b streptococcus. Polypeptides and nucleic acids from Streptococcus agalactiae which can be...
Invention Group b streptococcus. Polypeptides and nucleic acids from Streptococcus agalactiae which c...
2003 Invention Zinc activated ion channel. Novel zinc activated ion channel (ZAC) polypeptides, proteins and nuc...
2000 Invention Complete genome sequence of the methanogenic archaeon, methanococcus jannaschii. The present appl...